FDA Clears HoneyNaps Ai Software for Sleep Apnea Analysis
The USFDA granted 510(k) clearance for the HoneyNaps Somnum V3.0 Ai-based software for polysomnography (PSG) analysis, according to the company.
The USFDA granted 510(k) clearance for the HoneyNaps Somnum V3.0 Ai-based software for polysomnography (PSG) analysis, according to the company.
Global organizations unite to raise awareness and improve care for more than 1 million people living with bronchiectasis.
The FDA approved the first generic of Xofluza (baloxavir marboxil) tablets, the first single-dose treatment for acute uncomplicated influenza and prophylaxis in patients 5 years of age and older.
Michelle Ng Gong succeeds Raed Dweik as president of the American Thoracic Society.
Perma Pure and Maxtec have unified under a new parent company, Salaera, to form a global technology platform for breath and gas systems.
Benralizumab (Fasenra) is now indicated to reduce the risk of flare ups for adult and pediatric patients with hypereosinophilic syndrome.
A manufacturing error in the ventilator motor assembly may cause mechanical ventilation to fail before or during use, according to an FDA early alert.